Total Funding
61
67
Total FundingSeed raised
Growth Score
-3 pts
Heat Score
-14 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
136214
Neurolytixs is a biotechnology company that develops health care technology to aid biomarker discovery for the diagnosis of concussions.
Peter George: Co-Founder, Chief Executive Officer & Board Member- Douglas Fraser: Co-Founder, Chief Medical Officer & Board Member
About the Company
Neurolytixs is a health care technology intended to aid biomarker discovery for the diagnosis of concussions. They have leveraged artificial intelligence to diagnose concussions with blood biomarker tests. They utilize machine learning, artificial intelligence, and blood tests, enabling the sports industry to better diagnose concussions on site.
